CA Stock MarketDetailed Quotes

RLSC RISE Life Science Corp

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Sep 9 09:30 ET
0Market Cap0.00P/E (TTM)

RISE Life Science Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2021
(Q2)May 31, 2021
(Q1)Feb 28, 2021
(FY)Nov 30, 2020
(Q4)Nov 30, 2020
(Q3)Aug 31, 2020
(Q2)May 31, 2020
(Q1)Feb 29, 2020
(FY)Nov 30, 2019
(Q4)Nov 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,143.74%-118.67K
-31.81%-115.67K
95.93%-3.39K
97.08%-207.49K
53.47%-27.01K
99.13%-9.54K
97.64%-87.75K
96.27%-83.19K
-78.93%-7.11M
89.52%-58.05K
Net income from continuing operations
90.28%-82.23K
863.52%4.88M
97.20%-18.17K
55.04%-3.2M
19.94%-1.07M
62.28%-845.77K
62.93%-639.67K
64.43%-647.88K
39.89%-7.13M
82.89%-1.34M
Operating gains losses
-189.81%-199.09K
-5,876.27%-5.28M
-80.69%-133.88K
2,593.59%73.11K
-75.31%13.89K
552.68%221.68K
5.26%-88.36K
-65,670.80%-74.1K
8.86%-2.93K
--56.26K
Depreciation and amortization
--0
-100.33%-61
-74.38%4.48K
31.85%69.57K
4.51%16.57K
30.37%17.04K
45.14%18.5K
57.36%17.47K
-82.60%52.77K
-86.98%15.85K
Asset impairment expenditure
250.21%28.89K
66,155.81%28.49K
--0
166.74%665.01K
165.96%655.38K
484.28%8.25K
--43
-9.29%1.34K
-95.92%249.31K
-95.97%246.42K
Remuneration paid in stock
----
----
--0
-98.29%5.03K
--0
--0
-92.12%2.17K
-98.66%2.85K
-65.10%293.81K
-83.24%10.88K
Other non cashItems
-66.89%121.86K
-107.21%-28.91K
-68.52%127.01K
20.52%1.43M
-40.70%261.04K
33.34%367.99K
43.43%401.18K
108.33%403.48K
165.91%1.19M
125.08%440.22K
Change In working capital
-94.62%11.9K
28.91%281.52K
-91.96%17.18K
142.56%750.38K
-80.96%97.08K
-71.75%221.27K
109.81%218.39K
125.76%213.65K
-1,092.87%-1.76M
-33.67%509.81K
-Change in receivables
-16,323.26%-28.25K
210.97%54.59K
100.74%270
-106.79%-24.68K
-102.52%-5.43K
-100.06%-172
118.70%17.56K
33.87%-36.63K
245.43%363.46K
412.66%215.62K
-Change in inventory
-111.85%-52
--0
35.61%3.08K
-96.42%4.12K
100.44%155
-99.81%439
109.99%1.25K
103.06%2.27K
164.38%114.93K
69.53%-34.84K
-Change in prepaid assets
-94.79%1.16K
--0
-99.04%568
91.67%136.38K
-86.33%7.07K
369.10%22.32K
135.39%47.98K
-60.73%59.01K
135.09%71.15K
169.75%51.71K
-Change in payables and accrued expense
-80.35%39.04K
62.51%226.93K
-93.40%13.26K
261.75%646.34K
-19.92%107.06K
-26.89%198.68K
210.87%139.64K
123.64%200.95K
-149.41%-399.59K
-86.95%133.69K
-Change in other working capital
----
----
----
99.38%-11.77K
----
----
----
---11.96K
---1.91M
--143.62K
Cash from discontinued investing activities
Operating cash flow
-1,143.74%-118.67K
-31.81%-115.67K
95.93%-3.39K
97.08%-207.49K
53.61%-27.01K
99.13%-9.54K
97.64%-87.75K
96.27%-83.19K
-78.93%-7.11M
89.49%-58.23K
Investing cash flow
Cash flow from continuing investing activities
0
87.44%-68.38K
0
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
-185.97%-68.38K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
87.44%-68.38K
--0
Financing cash flow
Cash flow from continuing financing activities
118.67K
-15.94%31.54K
240.93%20K
-99.38%22.04K
99.04%-1.29K
0
-98.40%37.52K
-101.04%-14.19K
-51.47%3.55M
-103.71%-134.2K
Net issuance payments of debt
--0
--0
101.03%20K
-153.58%-1.9M
99.04%-1.29K
--0
102.74%37.52K
-241.69%-1.94M
-4.79%3.55M
-103.60%-134.2K
Net common stock issuance
--0
----
----
----
----
----
----
----
----
----
Net other financing activities
--118.67K
----
----
--1.93M
--0
--0
--0
--1.93M
----
----
Cash from discontinued financing activities
Financing cash flow
--118.67K
-15.94%31.54K
240.93%20K
-99.38%22.04K
99.04%-1.29K
--0
-98.40%37.52K
-101.04%-14.19K
-51.47%3.55M
-103.71%-134.2K
Net cash flow
Beginning cash position
-98.65%1.45K
-45.31%85.64K
-72.83%69.06K
-93.45%254.17K
-78.39%96.76K
-93.23%107.3K
-94.73%156.59K
-93.45%254.17K
263.81%3.88M
-45.88%447.81K
Current changes in cash
100.07%7
-67.49%-84.12K
117.06%16.62K
94.88%-185.44K
85.70%-27.51K
99.09%-10.32K
96.40%-50.23K
89.25%-97.38K
-229.28%-3.62M
-106.33%-192.42K
Effect of exchange rate changes
134.60%73
-107.37%-69
81.68%-37
209.48%335
84.49%-188
97.51%-211
-92.22%936
92.39%-202
-103.35%-306
-110.46%-1.21K
End cash Position
-98.42%1.53K
-98.65%1.45K
-45.31%85.64K
-72.83%69.06K
-72.83%69.06K
-78.39%96.76K
-93.23%107.3K
-94.73%156.59K
-93.45%254.17K
-93.45%254.17K
Free cash from
-1,143.74%-118.67K
-31.81%-115.67K
95.93%-3.39K
97.11%-207.49K
53.61%-27.01K
99.14%-9.54K
97.65%-87.75K
96.34%-83.19K
-53.19%-7.18M
89.72%-58.23K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2021(Q2)May 31, 2021(Q1)Feb 28, 2021(FY)Nov 30, 2020(Q4)Nov 30, 2020(Q3)Aug 31, 2020(Q2)May 31, 2020(Q1)Feb 29, 2020(FY)Nov 30, 2019(Q4)Nov 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,143.74%-118.67K-31.81%-115.67K95.93%-3.39K97.08%-207.49K53.47%-27.01K99.13%-9.54K97.64%-87.75K96.27%-83.19K-78.93%-7.11M89.52%-58.05K
Net income from continuing operations 90.28%-82.23K863.52%4.88M97.20%-18.17K55.04%-3.2M19.94%-1.07M62.28%-845.77K62.93%-639.67K64.43%-647.88K39.89%-7.13M82.89%-1.34M
Operating gains losses -189.81%-199.09K-5,876.27%-5.28M-80.69%-133.88K2,593.59%73.11K-75.31%13.89K552.68%221.68K5.26%-88.36K-65,670.80%-74.1K8.86%-2.93K--56.26K
Depreciation and amortization --0-100.33%-61-74.38%4.48K31.85%69.57K4.51%16.57K30.37%17.04K45.14%18.5K57.36%17.47K-82.60%52.77K-86.98%15.85K
Asset impairment expenditure 250.21%28.89K66,155.81%28.49K--0166.74%665.01K165.96%655.38K484.28%8.25K--43-9.29%1.34K-95.92%249.31K-95.97%246.42K
Remuneration paid in stock ----------0-98.29%5.03K--0--0-92.12%2.17K-98.66%2.85K-65.10%293.81K-83.24%10.88K
Other non cashItems -66.89%121.86K-107.21%-28.91K-68.52%127.01K20.52%1.43M-40.70%261.04K33.34%367.99K43.43%401.18K108.33%403.48K165.91%1.19M125.08%440.22K
Change In working capital -94.62%11.9K28.91%281.52K-91.96%17.18K142.56%750.38K-80.96%97.08K-71.75%221.27K109.81%218.39K125.76%213.65K-1,092.87%-1.76M-33.67%509.81K
-Change in receivables -16,323.26%-28.25K210.97%54.59K100.74%270-106.79%-24.68K-102.52%-5.43K-100.06%-172118.70%17.56K33.87%-36.63K245.43%363.46K412.66%215.62K
-Change in inventory -111.85%-52--035.61%3.08K-96.42%4.12K100.44%155-99.81%439109.99%1.25K103.06%2.27K164.38%114.93K69.53%-34.84K
-Change in prepaid assets -94.79%1.16K--0-99.04%56891.67%136.38K-86.33%7.07K369.10%22.32K135.39%47.98K-60.73%59.01K135.09%71.15K169.75%51.71K
-Change in payables and accrued expense -80.35%39.04K62.51%226.93K-93.40%13.26K261.75%646.34K-19.92%107.06K-26.89%198.68K210.87%139.64K123.64%200.95K-149.41%-399.59K-86.95%133.69K
-Change in other working capital ------------99.38%-11.77K---------------11.96K---1.91M--143.62K
Cash from discontinued investing activities
Operating cash flow -1,143.74%-118.67K-31.81%-115.67K95.93%-3.39K97.08%-207.49K53.61%-27.01K99.13%-9.54K97.64%-87.75K96.27%-83.19K-78.93%-7.11M89.49%-58.23K
Investing cash flow
Cash flow from continuing investing activities 087.44%-68.38K0
Net PPE purchase and sale --------------0-----------------185.97%-68.38K--0
Cash from discontinued investing activities
Investing cash flow --------------0----------------87.44%-68.38K--0
Financing cash flow
Cash flow from continuing financing activities 118.67K-15.94%31.54K240.93%20K-99.38%22.04K99.04%-1.29K0-98.40%37.52K-101.04%-14.19K-51.47%3.55M-103.71%-134.2K
Net issuance payments of debt --0--0101.03%20K-153.58%-1.9M99.04%-1.29K--0102.74%37.52K-241.69%-1.94M-4.79%3.55M-103.60%-134.2K
Net common stock issuance --0------------------------------------
Net other financing activities --118.67K----------1.93M--0--0--0--1.93M--------
Cash from discontinued financing activities
Financing cash flow --118.67K-15.94%31.54K240.93%20K-99.38%22.04K99.04%-1.29K--0-98.40%37.52K-101.04%-14.19K-51.47%3.55M-103.71%-134.2K
Net cash flow
Beginning cash position -98.65%1.45K-45.31%85.64K-72.83%69.06K-93.45%254.17K-78.39%96.76K-93.23%107.3K-94.73%156.59K-93.45%254.17K263.81%3.88M-45.88%447.81K
Current changes in cash 100.07%7-67.49%-84.12K117.06%16.62K94.88%-185.44K85.70%-27.51K99.09%-10.32K96.40%-50.23K89.25%-97.38K-229.28%-3.62M-106.33%-192.42K
Effect of exchange rate changes 134.60%73-107.37%-6981.68%-37209.48%33584.49%-18897.51%-211-92.22%93692.39%-202-103.35%-306-110.46%-1.21K
End cash Position -98.42%1.53K-98.65%1.45K-45.31%85.64K-72.83%69.06K-72.83%69.06K-78.39%96.76K-93.23%107.3K-94.73%156.59K-93.45%254.17K-93.45%254.17K
Free cash from -1,143.74%-118.67K-31.81%-115.67K95.93%-3.39K97.11%-207.49K53.61%-27.01K99.14%-9.54K97.65%-87.75K96.34%-83.19K-53.19%-7.18M89.72%-58.23K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg